Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 246.36
BSDM's Cash to Debt is ranked higher than
83% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. BSDM: 246.36 )
BSDM' s 10-Year Cash to Debt Range
Min: 4.22   Max: No Debt
Current: 246.36

Equity to Asset 0.87
BSDM's Equity to Asset is ranked higher than
91% of the 446 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. BSDM: 0.87 )
BSDM' s 10-Year Equity to Asset Range
Min: 0.26   Max: 0.97
Current: 0.87

0.26
0.97
Interest Coverage No Debt
BSDM's Interest Coverage is ranked higher than
73% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 235.10 vs. BSDM: No Debt )
BSDM' s 10-Year Interest Coverage Range
Min: 16.98   Max: 9999.99
Current: No Debt

16.98
9999.99
F-Score: 6
Z-Score: -1.31
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -134.15
BSDM's Operating margin (%) is ranked higher than
51% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. BSDM: -134.15 )
BSDM' s 10-Year Operating margin (%) Range
Min: -472.69   Max: 30.78
Current: -134.15

-472.69
30.78
Net-margin (%) -134.04
BSDM's Net-margin (%) is ranked higher than
51% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. BSDM: -134.04 )
BSDM' s 10-Year Net-margin (%) Range
Min: -471.37   Max: 515.82
Current: -134.04

-471.37
515.82
ROE (%) -69.73
BSDM's ROE (%) is ranked lower than
51% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. BSDM: -69.73 )
BSDM' s 10-Year ROE (%) Range
Min: -171.85   Max: 1026.92
Current: -69.73

-171.85
1026.92
ROA (%) -58.98
BSDM's ROA (%) is ranked higher than
51% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. BSDM: -58.98 )
BSDM' s 10-Year ROA (%) Range
Min: -66.3   Max: 126.56
Current: -58.98

-66.3
126.56
ROC (Joel Greenblatt) (%) -254.14
BSDM's ROC (Joel Greenblatt) (%) is ranked higher than
55% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. BSDM: -254.14 )
BSDM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -426.87   Max: 164.08
Current: -254.14

-426.87
164.08
Revenue Growth (3Y)(%) -24.10
BSDM's Revenue Growth (3Y)(%) is ranked higher than
52% of the 340 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. BSDM: -24.10 )
BSDM' s 10-Year Revenue Growth (3Y)(%) Range
Min: -35.6   Max: 55.4
Current: -24.1

-35.6
55.4
EBITDA Growth (3Y)(%) -3.60
BSDM's EBITDA Growth (3Y)(%) is ranked higher than
72% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. BSDM: -3.60 )
BSDM' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -30.7   Max: 94.3
Current: -3.6

-30.7
94.3
EPS Growth (3Y)(%) -19.60
BSDM's EPS Growth (3Y)(%) is ranked higher than
65% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. BSDM: -19.60 )
BSDM' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 26
Current: -19.6

0
26
» BSDM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

BSDM Guru Trades in

BSDM Guru Trades in

BSDM Guru Trades in

Q3 2014

BSDM Guru Trades in Q3 2014

Jim Simons 82,100 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with BSDM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 1.40
BSDM's P/B is ranked higher than
92% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.95 vs. BSDM: 1.40 )
BSDM' s 10-Year P/B Range
Min: 1.23   Max: 17.73
Current: 1.4

1.23
17.73
P/S 2.10
BSDM's P/S is ranked higher than
78% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. BSDM: 2.10 )
BSDM' s 10-Year P/S Range
Min: 2.08   Max: 87.88
Current: 2.1

2.08
87.88
EV-to-EBIT -0.83
BSDM's EV-to-EBIT is ranked lower than
56% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 61.55 vs. BSDM: -0.83 )
BSDM' s 10-Year EV-to-EBIT Range
Min: -71.1   Max: -0.6
Current: -0.83

-71.1
-0.6
Current Ratio 6.92
BSDM's Current Ratio is ranked higher than
90% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. BSDM: 6.92 )
BSDM' s 10-Year Current Ratio Range
Min: 1.29   Max: 40.45
Current: 6.92

1.29
40.45
Quick Ratio 5.45
BSDM's Quick Ratio is ranked higher than
90% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. BSDM: 5.45 )
BSDM' s 10-Year Quick Ratio Range
Min: 0.42   Max: 36.37
Current: 5.45

0.42
36.37

Valuation & Return

vs
industry
vs
history
Price/Net Cash 2.20
BSDM's Price/Net Cash is ranked higher than
99% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. BSDM: 2.20 )
BSDM' s 10-Year Price/Net Cash Range
Min: 3.04   Max: 87.5
Current: 2.2

3.04
87.5
Price/Net Current Asset Value 1.80
BSDM's Price/Net Current Asset Value is ranked higher than
99% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. BSDM: 1.80 )
BSDM' s 10-Year Price/Net Current Asset Value Range
Min: 2.92   Max: 256.2
Current: 1.8

2.92
256.2
Price/Tangible Book 1.30
BSDM's Price/Tangible Book is ranked higher than
95% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 6.92 vs. BSDM: 1.30 )
BSDM' s 10-Year Price/Tangible Book Range
Min: 2.39   Max: 42.7
Current: 1.3

2.39
42.7
Price/Median PS Value 0.10
BSDM's Price/Median PS Value is ranked higher than
100% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. BSDM: 0.10 )
BSDM' s 10-Year Price/Median PS Value Range
Min: 0.12   Max: 5.34
Current: 0.1

0.12
5.34
Earnings Yield (Greenblatt) -120.50
BSDM's Earnings Yield (Greenblatt) is ranked lower than
57% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. BSDM: -120.50 )
BSDM' s 10-Year Earnings Yield (Greenblatt) Range
Min: -120.5   Max: 0
Current: -120.5

-120.5
0

Analyst Estimate

Mar15
EPS($) -0.08
EPS without NRI($) -0.08

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:BZD.Germany,
BSD Medical Corp was originally incorporated under the laws of the State of Utah on March 17, 1978. On July 3, 1986, the Company was reincorporated in the State of Delaware The Company develops, manufactures, market and services systems to treat cancer and benign diseases using heat therapy delivered using focused radiofrequency (RF) and microwave energy. Its product line for cancer therapy has been created to offer hospitals and clinics a complete solution for thermal treatment of cancer using microwave/RF systems. Microwave ablation system is used to ablate (destroy) soft tissue with heat alone. Thermal ablation is used to destroy local tumors using a short intense focus of heat on a specific area, which is usually small, similar to surgical removal of the tumor. Its product line includes systems that have been strategically designed to offer a range of thermal treatment systems for the treatment of cancer, including both hyperthermia and ablation treatment systems. Current and future cancer treatment sites for its systems may include cancers of the prostate, breast, head, neck, bladder, cervix, colon/rectum, ovaries, esophagus, liver, kidney, brain, bone, stomach and lung. The BSD-500 comes in several versions, depending on the customer requirements. The BSD-2000 Hyperthermia System, or the BSD-2000, family of products includes the BSD-2000, the BSD-2000/3D and the BSD-2000/3D/MR. These systems non-invasively deliver localized therapeutic heating (hyperthermia) to solid tumors by applying radiofrequency (RF) energy to certain cancerous tumors, including those located deep within the body. These systems consist of four major subsystems: an RF power generator delivery subsystem; a proprietary, thermistor-based, thermometry subsystem; a computerized monitoring and control subsystem; and an applicator subsystem that includes an applicator and patient support system; as well as various accessories. As a further enhancement of the BSD-2000/3D, it has added to it the option of concurrent magnetic resonance imaging, or MRI, used for non-invasively monitoring the tissue temperatures during delivery of deep hyperthermia therapy. Its target customers include clinics, hospitals and institutions in which cancer is treated, located either in the United States or international markets. The company generally provides a 12-month warranty and record a liability for the warranty following installation on all cancer treatment systems and a 90-day limited warranty on individual components. Competitors in the thermal ablation market include RadioTherapeutics, a division of Boston Scientific Corporation, Covidien Ltd., Angiodynamics, Inc. and Microsulis Medical Ltd. The medical devices that it has developed and is developing are subject to extensive and rigorous regulation by numerous governmental authorities, principally by the FDA, and comparable foreign agencies.
» More Articles for BSDM

Headlines

Articles On GuruFocus.com
BSD Medical Corp. Reports Operating Results (10-Q) Jan 14 2011 
BSD Medical Corp. Reports Operating Results (10-K) Nov 29 2010 
BSD Medical Corp. Reports Operating Results (10-Q) Jan 14 2010 
BSD Medical Corp. Reports Operating Results (10-Q) Jul 10 2009 
BSD Medical Corp. Reports Operating Results (10-Q) Apr 09 2009 
BSD Medical Corp. Reports Operating Results for Fiscal Quarter Ended on 2008-11-30 Jan 10 2009 

More From Other Websites
BSD MEDICAL CORP Financials Nov 21 2014
10-K for BSD Medical Corp. Nov 15 2014
BSD MEDICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 14 2014
BSD MEDICAL CORP Files SEC form 10-K, Annual Report Nov 13 2014
BSD Medical Announces Fiscal Year 2014 Financial Results Nov 13 2014
BSD Medical Announces Fiscal Year 2014 Financial Results Nov 13 2014
BSD MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers Nov 12 2014
BSD Medical Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Nov 12 2014
BSD Medical Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Nov 12 2014
BSD Medical Names Medical Device Veteran Clint Carnell President and Chief Executive Officer Nov 10 2014
BSD Medical Names Medical Device Veteran Clint Carnell President and Chief Executive Officer Nov 10 2014
BSD Medical Reports Findings from Study Sponsored by Terumo Europe N.V. Using MicroThermX®... Oct 24 2014
BSD Medical Reports Findings from Study Sponsored by Terumo Europe N.V. Using MicroThermX®... Oct 24 2014
BSD Medical Expands Distribution Network to Fully Cover Entire United States Oct 15 2014
BSD Medical Expands Distribution Network to Fully Cover Entire United States Oct 15 2014
BSD Medical’s China Distributor Receives China Food and Drug Administration Marketing and Import... Sep 29 2014
BSD Announces the Opening of the Center for Treatment of Children with Hyperthermia and Chemotherapy... Sep 25 2014
Terumo Europe NV Showcases BSD Medical’s MicroThermX® at CIRSE Sep 22 2014
Terumo Europe NV Showcases BSD Medical’s MicroThermX® at CIRSE Sep 22 2014
BSD MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Sep 19 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK